US Stock MarketDetailed Quotes

Virax Biolabs (VRAX)

Watchlist
  • 0.1596
  • +0.0007+0.44%
Close Apr 24 16:00 ET
  • 0.1530
  • -0.0066-4.14%
Post 20:01 ET
1.18MMarket Cap-0.13P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Virax Biolabs (VRAX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2025
(FY)Mar 31, 2024
(FY)Mar 31, 2023
(FY)Mar 31, 2022
(FY)Mar 31, 2021
(FY)Mar 31, 2020
Total revenue
-95.95%6.33K
1,727.11%156.42K
8.56K
0
23.97%123.82K
99.88K
Operating revenue
-95.95%6.33K
1,727.11%156.42K
--8.56K
--0
23.97%123.82K
--99.88K
Cost of revenue
-43.87%59.4K
966.18%105.83K
9.93K
0
146.19%133.25K
54.13K
Gross profit
-204.90%-53.07K
3,806.23%50.59K
-1.37K
0
-120.62%-9.43K
45.75K
Operating expense
-0.76%6.11M
7.42%6.16M
230.59%5.73M
172.98%1.73M
-8.88%635.1K
696.99K
Selling and administrative expenses
-5.76%4.33M
29.35%4.59M
173.25%3.55M
152.47%1.3M
-15.59%514.88K
--609.99K
-Selling and marketing expense
----
----
----
----
643.86%57.2K
--7.69K
-General and administrative expense
-5.76%4.33M
29.35%4.59M
173.25%3.55M
184.03%1.3M
-24.01%457.68K
--602.3K
Research and development costs
13.95%1.78M
-28.33%1.56M
402.45%2.18M
260.79%433.74K
38.19%120.22K
--87K
Operating profit
-0.93%-6.16M
-6.51%-6.11M
-230.67%-5.73M
-168.98%-1.73M
1.03%-644.54K
-651.24K
Net non-operating interest income expense
-116.46%-58.18K
-73.77%-26.88K
-0.19%-15.47K
46.10%-15.44K
68.42%-28.64K
-90.69K
Non-operating interest expense
116.46%58.18K
73.77%26.88K
0.19%15.47K
-46.10%15.44K
-68.42%28.64K
--90.69K
Other net income (expense)
102.83%17.18K
-308.67%-606.12K
38,674.50%290.47K
-383.08%-753
-89.23%266
2.47K
Special income (charges)
--0
---390.36K
--0
--0
----
----
-Less:Impairment of capital assets
--0
--390.36K
--0
--0
----
----
Other non- operating income (expenses)
107.96%17.18K
-174.28%-215.77K
38,674.50%290.47K
-383.08%-753
-89.23%266
--2.47K
Income before tax
7.94%-6.2M
-23.48%-6.74M
-211.90%-5.46M
-160.04%-1.75M
9.00%-672.92K
-739.46K
Income tax
-136.66K
0
0
0
0
0
Net income
9.97%-6.07M
-23.48%-6.74M
-211.90%-5.46M
-160.04%-1.75M
9.00%-672.92K
-739.46K
Net income continuous Operations
9.97%-6.07M
-23.48%-6.74M
-211.90%-5.46M
-160.04%-1.75M
9.00%-672.92K
---739.46K
Minority interest income
-7.20%-5.99K
-1,975.46%-5.58K
99.34%-269
-87.15%-41.04K
24.44%-21.93K
-29.02K
Net income attributable to the parent company
9.98%-6.06M
-23.38%-6.73M
-219.37%-5.46M
-162.50%-1.71M
8.37%-650.98K
-710.44K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
9.98%-6.06M
-23.38%-6.73M
-219.37%-5.46M
-162.50%-1.71M
8.37%-650.98K
-710.44K
Basic earnings per share
51.79%-1.62
34.50%-3.36
-241.46%-5.13
-162.50%-1.5024
8.37%-0.5723
-0.6246
Diluted earnings per share
51.79%-1.62
34.50%-3.36
-241.46%-5.13
-162.50%-1.5024
8.37%-0.5723
-0.6246
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
(FY)Mar 31, 2025(FY)Mar 31, 2024(FY)Mar 31, 2023(FY)Mar 31, 2022(FY)Mar 31, 2021(FY)Mar 31, 2020
Total revenue -95.95%6.33K1,727.11%156.42K8.56K023.97%123.82K99.88K
Operating revenue -95.95%6.33K1,727.11%156.42K--8.56K--023.97%123.82K--99.88K
Cost of revenue -43.87%59.4K966.18%105.83K9.93K0146.19%133.25K54.13K
Gross profit -204.90%-53.07K3,806.23%50.59K-1.37K0-120.62%-9.43K45.75K
Operating expense -0.76%6.11M7.42%6.16M230.59%5.73M172.98%1.73M-8.88%635.1K696.99K
Selling and administrative expenses -5.76%4.33M29.35%4.59M173.25%3.55M152.47%1.3M-15.59%514.88K--609.99K
-Selling and marketing expense ----------------643.86%57.2K--7.69K
-General and administrative expense -5.76%4.33M29.35%4.59M173.25%3.55M184.03%1.3M-24.01%457.68K--602.3K
Research and development costs 13.95%1.78M-28.33%1.56M402.45%2.18M260.79%433.74K38.19%120.22K--87K
Operating profit -0.93%-6.16M-6.51%-6.11M-230.67%-5.73M-168.98%-1.73M1.03%-644.54K-651.24K
Net non-operating interest income expense -116.46%-58.18K-73.77%-26.88K-0.19%-15.47K46.10%-15.44K68.42%-28.64K-90.69K
Non-operating interest expense 116.46%58.18K73.77%26.88K0.19%15.47K-46.10%15.44K-68.42%28.64K--90.69K
Other net income (expense) 102.83%17.18K-308.67%-606.12K38,674.50%290.47K-383.08%-753-89.23%2662.47K
Special income (charges) --0---390.36K--0--0--------
-Less:Impairment of capital assets --0--390.36K--0--0--------
Other non- operating income (expenses) 107.96%17.18K-174.28%-215.77K38,674.50%290.47K-383.08%-753-89.23%266--2.47K
Income before tax 7.94%-6.2M-23.48%-6.74M-211.90%-5.46M-160.04%-1.75M9.00%-672.92K-739.46K
Income tax -136.66K00000
Net income 9.97%-6.07M-23.48%-6.74M-211.90%-5.46M-160.04%-1.75M9.00%-672.92K-739.46K
Net income continuous Operations 9.97%-6.07M-23.48%-6.74M-211.90%-5.46M-160.04%-1.75M9.00%-672.92K---739.46K
Minority interest income -7.20%-5.99K-1,975.46%-5.58K99.34%-269-87.15%-41.04K24.44%-21.93K-29.02K
Net income attributable to the parent company 9.98%-6.06M-23.38%-6.73M-219.37%-5.46M-162.50%-1.71M8.37%-650.98K-710.44K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 9.98%-6.06M-23.38%-6.73M-219.37%-5.46M-162.50%-1.71M8.37%-650.98K-710.44K
Basic earnings per share 51.79%-1.6234.50%-3.36-241.46%-5.13-162.50%-1.50248.37%-0.5723-0.6246
Diluted earnings per share 51.79%-1.6234.50%-3.36-241.46%-5.13-162.50%-1.50248.37%-0.5723-0.6246
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -